Trial intelligence / Profile preview

Exploratory PK/PD study of beta-lactam antibiotics in pediatric intensive care patients

NL-OMON29496Not yet recruiting

Sponsor
MRace
Start
May 2021
Countries
1
01

Overview

Open-label, single-arm trial in Infectious disease, sponsored by MRace. Primary endpoint: Prevalence of pharmacodynamic target attainment. Planned start May 2021; status: not yet recruiting.

02

Conditions

Infectious disease

Beyond the preview

Go deeper on NL-OMON29496.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON29496.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call